| 000 | 01673 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250513113254.0 | ||
| 264 | 0 | _c19970527 | |
| 008 | 199705s 0 0 eng d | ||
| 022 | _a0006-8993 | ||
| 024 | 7 |
_a10.1016/s0006-8993(96)01297-8 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLai, C C | |
| 245 | 0 | 0 |
_aExcitatory action of pituitary adenylate cyclase activating polypeptide on rat sympathetic preganglionic neurons in vivo and in vitro. _h[electronic resource] |
| 260 |
_bBrain research _cFeb 1997 |
||
| 300 |
_a189-94 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntihypertensive Agents _xpharmacology |
| 650 | 0 | 4 |
_aBlood Pressure _xdrug effects |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aElectrophysiology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGanglia, Sympathetic _xcytology |
| 650 | 0 | 4 |
_aGlutamic Acid _xpharmacology |
| 650 | 0 | 4 | _aIn Vitro Techniques |
| 650 | 0 | 4 | _aInjections, Intravenous |
| 650 | 0 | 4 | _aInjections, Spinal |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aNeurons _xdrug effects |
| 650 | 0 | 4 |
_aNeuropeptides _xpharmacology |
| 650 | 0 | 4 |
_aPhentolamine _xpharmacology |
| 650 | 0 | 4 | _aPituitary Adenylate Cyclase-Activating Polypeptide |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aSubstance P _xpharmacology |
| 650 | 0 | 4 |
_aVasoactive Intestinal Peptide _xpharmacology |
| 700 | 1 | _aWu, S Y | |
| 700 | 1 | _aLin, H H | |
| 700 | 1 | _aDun, N J | |
| 773 | 0 |
_tBrain research _gvol. 748 _gno. 1-2 _gp. 189-94 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0006-8993(96)01297-8 _zAvailable from publisher's website |
| 999 |
_c9055020 _d9055020 |
||